| API | Produit Numm | FALL NR. | Klassifikatioun |
| HQC23838 | Sulfapyridin | 144-83-2 | Antibiotiken |
| PF-07321332 (Medikament fir Paxlovid) | (1R,2S,5S)-6,6-DIMETHYL-3-AZA-BICYCLO[3.1.0]HEXAN-2-CARBOXYLIC Acid METHYL ESTER HYDROCHLORID | 565456-77-1 | COVID 19 |
| PF-07321333 (Medikament fir Paxlovid) | L-Valine, 3-methyl-N-(trifluoracetyl)- (9CI) | 666832-71-9 | COVID 19 |
| PF-07321334 (Medikament fir Paxlovid) | (αS,3S)-α-[(tert-Butyloxycarbonyl)aMino]-2-oxo-3-pyrrolidinpropansäure Methylester | 328086-60-8 | COVID 19 |
| PF-07321335 (Medikament fir Paxlovid) | 6,6-Dimethyl-3-azabicyclo[3.1.0]hexan | 943516-54-9 | COVID 19 |
| PF-07321336 (Medikament fir Paxlovid) | Dimethyl (2S,4R)-2-(Boc-amino)-4-(cyanomethyl)pentandioat | 328086-57-3 | COVID 19 |
| PF-07321337 (Medikament fir Paxlovid) | 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimidhydrochlorid | 25952-53-8 | COVID 19 |
| PF-07321338 (Medikament fir Paxlovid) | 2-Hydroxypyridine 1-Oxid (HOPO) | 13161-30-3 | COVID 19 |
| PF-07321339 (Medikament fir Paxlovid) | Lithiumhydroxid | 1310-65-2 | COVID 19 |
| PF-07321340 (Medikament fir Paxlovid) | 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate (HATU) | 148893-10-1 | COVID 19 |
| apixaban | Essigsäure, 2-chlor-2-[2-(4-methoxyphenyl)hydrazinyliden], Ethylester | 27143-07-3 | Kardiovaskulär |
| apixaban | 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-on | 545445-44-1 | Kardiovaskulär |
| Sacubitril | LCZ696 | 1426129-50-1 | Kardiovaskulär |
| Sacubitril | (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentansäure | 1012341-50-2 | Kardiovaskulär |
| Sacubitril | AHU 377 | 149709-62-6 | Kardiovaskulär |
| Ticagrelor | 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol-L-Tatarsäure | 376608-65-0 | Kardiovaskulär |
| Ticagrelor | (1R,2S)-2-(3,4-Difluorphenyl)cyclopropanaminium(2R)-Hydroxy(phenyl)ethanoate | 376608-71-8 | Kardiovaskulär |
| Ticagrelor | Cyclopropanamine, 2-(3,4-difluorphenyl)-(1R,2S)-(2R,3R)-2,3-dihydroxybutandioat | 220352-39-6 | Kardiovaskulär |
| Ticagrelor | 4,6-Dichlor-2-propylthiopyrimidin-5-amine | 145783-15-9 | Kardiovaskulär |
| Quinapril | (S)-1,2,3,4-Tetrahydro-3-isoquinolincarboxylsäure | 74163-81-8 | Kardiovaskulär |
| Rosuvastatin | Z-9: 4-(4-Fluorphenyl)-6-Isopropyl-2-[(N-methyl-N-methylsulfonyl)amino]pyrimidinyl-5-ylformyl | 147118-37-4 | Kardiovaskulär |
| Rosuvastatin | Z-7: 4-(4-fluorphenyl)-6-isopropyl-2-[(N-methyl-N-methylsulfonyl)amino]pyrimidin-5-yl-methanol | 147118-36-3 | Kardiovaskulär |
| Rivaroxaban | 4-(4-Aminophenyl)morpholin-3-on | 438056-69-0 | Kardiovaskulär |
| Rivaroxaban | 5-Chlorothiophene-2-Carboxylsäure | 24065-33-6 | Kardiovaskulär |
| Rivaroxaban | (S)-(+)-N-(2,3-Epoxypropyl)phthalimide | 161596-47-0 | Kardiovaskulär |
| Clopidogrel | Thiophen-2-Ethanol | 5402-55-1 | Kardiovaskulär |
| Clopidogrel | 4,5,6,7-Tetrahydro-thieno[3,2-c]pyridin HCl | 28783-41-7 | Kardiovaskulär |
| Patiromer | Methyl-2-Fluoracrylat | 2343-89-7 | Kardiovaskulär |
| Ezetimibe | (3R,4S)-4-(4-(Benzyloxy)Phenyl)-1-(4-Fluorphenyl)-3-((S)-3-(4-fluorphenyl)-3-Hydroxypropyl)Azetidin-2-One | 163222-32-0 | Kardiovaskulär |
| Fenofibrat | Fenofibratsäure: (2-[4-(4-chlorbenzoyl)phenoxy]-2-Methylpropionsäure) | 42017-89-0 | Kardiovaskulär |
| Edoxaban | Ethyl-2-((5-chlorpyridin-2-yl)amino)-2-oxoacetat-hydrochlorid | 1243308-37-3 | Kardiovaskulär |
| Edoxaban | 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-Carboxylsäure-Hydrochlorid | 720720-96-7 | Kardiovaskulär |
| Edoxaban | Tert-Butyl(1R,2S,5S)-2-azido-5-[(dimethylamino)carbonyl]cyclohexylcarbamatoxalsäure | 1353893-22-7 | Kardiovaskulär |
| donorguat | 5-fluor-1-(2-fluorbenzyl)-1H-pyrazolo[3,4-b]pyridin-3-carbonitril | 1350653-26-7 | Kardiovaskulär |
| Sotagliflozin | 4-Jod-1-chlor-2-(4-ethoxybenzyl)benzen | 1103738-29-9 | Diabetis |
| Sotagliflozin | D-xylo-pentodialdo-5,2-furanose, 4,5-O-(1-Methylethyliden)-1-C-4-Morpholinyl-,(5S)- | 1103738-19-7 | Diabetis |
| Sotagliflozin | D-xylo-pentodialdo-5,2-furanose, 1-C-[4-chlor-3-[(4-ethoxyphenyl)methyl]phenyl]-4,5-O-(1-Methylethyliden)-,(5S) - | 1103738-30-2 | Diabetis |
| Sotagliflozin | 5-Brom-2-chlor-4'-ethoxydiphenylmethan | 461432-23-5 | Diabetis |
| Canagliflozin | 2-(4-FLUOROPHENYL)THIOPHENE | 58861-48-6 | Diabetis |
| Canagliflozin | 5-Brom-2-methylbenzoic sauerem | 79669-49-1 | Diabetis |
